Literature DB >> 511955

Reversible inactivation of autosomal alleles in Chinese hamster cells.

W E Bradley.   

Abstract

Evidence is presented which suggests that a CHO-derived thymidine kinase (Tk) heterozygote, ts201, can reversibly inactivate the wild type Tk allele, and that this event may result in simultaneous inactivation of a linked allele, galactokinase (Glk). The clone ts201 was isolated as a revertant of a stable Tk- 5-bromodeoxyuridine (BrdU)-resistant mutant of CHO. The reacquired Tk activity differed from that of the wild type with respect to Km and heat resistance, supporting the contention that ts201 was genetically heterozygous (Tk+/-). At frequencies varying from 0.02-0.5, segregants of ts201 could be isolated by cloning in BrdU at 39 degrees. These derivatives were phenotypically Tk- (by enzymology and by autoradiography of 3H-dT labeled cells), but after removal of BrdU, reacquired the Tk+ phenotype at frequencies varying randomly from clone to clone. From mutagenized populations of ts201 two variants were isolated, 71t and 72c, by selection at 39 degrees in 2-deoxygalactose (2-dgal). Resistance to 2-dgal has been correlated with a mutation in the gene for Glk, which is syntenic with that for Tk and evidence is presented suggesting that 71t and 72c are Glk+/-. Cloning efficiencies in doubly selective media and autoradiographic data showed that at 39 degrees a coordination existed between the levels of Tk and Glk, which in 71t was inverse, and in 72c, direct. These data led to the hypothesis that pairs of linked alleles can be inactivated or re-expressed simultaneously. The inactivating effect was temperature-sensitive, since at 33 degrees, the cloning efficiency in BrdU and in 2-dgal was very low.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 511955     DOI: 10.1002/jcp.1041010212

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

1.  Gene inactivation as a mechanism for the expression of recessive phenotypes.

Authors:  S G Grant; C E Campbell; C Duff; S L Toth; R G Worton
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

2.  A coordinate relationship between the GALK and the TK1 genes of the Chinese hamster.

Authors:  R P Wagner; S H Cox; R C Schoen
Journal:  Biochem Genet       Date:  1985-10       Impact factor: 1.890

3.  Mutation at autosomal loci of Chinese hamster ovary cells: involvement of a high-frequency event silencing two linked alleles.

Authors:  W E Bradley
Journal:  Mol Cell Biol       Date:  1983-07       Impact factor: 4.272

4.  Genetic instability at the adenine phosphoribosyltransferase locus in mouse L cells.

Authors:  J A Tischfield; J J Trill; Y I Lee; K Coy; M W Taylor
Journal:  Mol Cell Biol       Date:  1982-03       Impact factor: 4.272

Review 5.  Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants.

Authors:  L Larizza; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  Segregation of recessive phenotypes in somatic cell hybrids: role of mitotic recombination, gene inactivation, and chromosome nondisjunction.

Authors:  C E Campbell; R G Worton
Journal:  Mol Cell Biol       Date:  1981-04       Impact factor: 4.272

7.  Thymidine-kinase activity of cultured cells from individuals with inherited galactokinase deficiency.

Authors:  R C Schoen; S H Cox; R P Wagner
Journal:  Am J Hum Genet       Date:  1984-07       Impact factor: 11.025

8.  Model involving gene inactivation in the generation of autosomal recessive mutants in mammalian cells in culture.

Authors:  A E Simon; M W Taylor; W E Bradley; L H Thompson
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  Monoallelic chromatin conformation flanking long-range silenced domains in cancer-derived and normal cells.

Authors:  Domenic Di Paola; John Raelson; Emmanouil Rampakakis; Mark Basik; Maria Zannis-Hadjopoulos; W Edward C Bradley
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.